A detailed history of Laffer Tengler Investments transactions in Abb Vie Inc. stock. As of the latest transaction made, Laffer Tengler Investments holds 56,528 shares of ABBV stock, worth $9.33 Million. This represents 2.26% of its overall portfolio holdings.

Number of Shares
56,528
Previous 55,096 2.6%
Holding current value
$9.33 Million
Previous $9.45 Billion 18.13%
% of portfolio
2.26%
Previous 2.04%

Shares

26 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 04, 2024

BUY
$163.84 - $199.33 $234,618 - $285,440
1,432 Added 2.6%
56,528 $11.2 Billion
Q2 2024

Aug 14, 2024

BUY
$154.79 - $180.76 $1.82 Million - $2.13 Million
11,764 Added 27.15%
55,096 $9.45 Billion
Q1 2024

May 15, 2024

SELL
$159.82 - $182.1 $503,912 - $574,161
-3,153 Reduced 6.78%
43,332 $7.89 Billion
Q4 2023

Feb 08, 2024

BUY
$137.6 - $154.97 $393,260 - $442,904
2,858 Added 6.55%
46,485 $7.2 Billion
Q3 2023

Nov 14, 2023

SELL
$133.59 - $154.65 $405,712 - $469,672
-3,037 Reduced 6.51%
43,627 $6.5 Billion
Q2 2023

Aug 14, 2023

BUY
$132.51 - $164.9 $6.18 Million - $7.69 Million
46,664 New
46,664 $6.29 Billion
Q1 2023

May 09, 2023

BUY
$144.61 - $166.54 $190,162 - $219,000
1,315 Added 3.02%
44,795 $7.14 Billion
Q4 2022

Feb 10, 2023

BUY
$138.31 - $165.87 $1.35 Million - $1.62 Million
9,781 Added 29.02%
43,480 $7.03 Billion
Q3 2022

Nov 10, 2022

BUY
$134.21 - $153.93 $192,591 - $220,889
1,435 Added 4.45%
33,699 $4.52 Billion
Q2 2022

Aug 15, 2022

SELL
$137.62 - $174.96 $21,468 - $27,293
-156 Reduced 0.48%
32,264 $4.94 Billion
Q1 2022

May 13, 2022

SELL
$131.98 - $163.75 $361,097 - $448,020
-2,736 Reduced 7.78%
32,420 $5.26 Billion
Q4 2021

Feb 11, 2022

BUY
$107.43 - $135.93 $112,049 - $141,774
1,043 Added 3.06%
35,156 $4.76 Billion
Q3 2021

Nov 16, 2021

BUY
$106.4 - $120.78 $805,235 - $914,063
7,568 Added 28.51%
34,113 $3.68 Billion
Q2 2021

Aug 16, 2021

SELL
$105.21 - $117.21 $2.42 Million - $2.7 Million
-23,018 Closed
0 $0
Q1 2021

May 17, 2021

BUY
$102.3 - $112.62 $172,887 - $190,327
1,690 Added 7.92%
23,018 $2.49 Billion
Q4 2020

Jun 11, 2021

BUY
$80.49 - $108.67 $62,138 - $83,893
772 Added 3.76%
21,328 $2.25 Billion
Q4 2020

Feb 19, 2021

BUY
$80.49 - $108.67 $73,004 - $98,563
907 Added 4.62%
20,556 $2.2 Billion
Q3 2020

Jun 11, 2021

BUY
$85.91 - $100.83 $3,350 - $3,932
39 Added 0.2%
19,649 $1.72 Billion
Q3 2020

Nov 13, 2020

SELL
$85.91 - $100.83 $131,442 - $154,269
-1,530 Reduced 7.24%
19,610 $1.72 Billion
Q2 2020

Jun 11, 2021

SELL
$73.37 - $98.18 $4,989 - $6,676
-68 Reduced 0.32%
21,140 $2.08 Billion
Q2 2020

Aug 14, 2020

BUY
$73.37 - $98.18 $231,629 - $309,954
3,157 Added 17.49%
21,208 $2.08 Billion
Q1 2020

Apr 28, 2020

BUY
$64.5 - $97.79 $199,627 - $302,660
3,095 Added 20.69%
18,051 $1.38 Billion
Q4 2019

Feb 20, 2020

BUY
$72.13 - $90.25 $507,795 - $635,360
7,040 Added 88.93%
14,956 $1.32 Billion
Q3 2019

Nov 14, 2019

SELL
$62.98 - $75.72 $9,195 - $11,055
-146 Reduced 1.81%
7,916 $599 Million
Q2 2019

Aug 15, 2019

BUY
$65.7 - $83.98 $8,475 - $10,833
129 Added 1.63%
8,062 $586 Million
Q1 2019

May 14, 2019

BUY
$77.14 - $90.79 $611,951 - $720,237
7,933 New
7,933 $639 Million

Others Institutions Holding ABBV

About AbbVie Inc.


  • Ticker ABBV
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,768,099,968
  • Market Cap $292B
  • Description
  • AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...
More about ABBV
Track This Portfolio

Track Laffer Tengler Investments Portfolio

Follow Laffer Tengler Investments and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Laffer Tengler Investments, based on Form 13F filings with the SEC.

News

Stay updated on Laffer Tengler Investments with notifications on news.